跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABILIFY 15 MG COMPRIMIDOS BUCODISPERSABLES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ABILIFY 15 MG COMPRIMIDOS BUCODISPERSABLES
Approved
STANDARD
ABILIFY 15 MG COMPRIMIDOS BUCODISPERSABLES
Otsuka Pharmaceutical Netherlands B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 13, 2020
Approval ID
882741db291a3604
Company
Otsuka Pharmaceutical Netherlands B.V.
Type
Standard
Approval Details
Approval Id
882741db291a3604
Drug Cima Aemps Name
ABILIFY 15 MG COMPRIMIDOS BUCODISPERSABLES
Register Number
04276028IP
Holder Company Name
Otsuka Pharmaceutical Netherlands B.V.
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/otsuka-pharmaceutical-netherlands-b-v
Authorization Date
2020-07-13
Dosage Form
COMPRIMIDO BUCODISPERSABLE
Dose
15 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Otsuka Pharmaceutical Netherlands B.V.
Company Detail Path
/organization/otsuka-pharmaceutical-netherlands-b-v
Company Information
Pharmaceutical Company Name
Otsuka Pharmaceutical Netherlands B.V.
Country Name
Netherlands
Active Ingredients
ARIPIPRAZOL
15 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 13, 2020
Approval ID
882741db291a3604
Type
Standard
Back to CIMA-AEMPS Approvals